ASX - By Stock
|
ATH Biotech |
Re:
Stock price - ATH/ATHE
|
|
vultureculture
|
2.4K |
800K |
3 |
10/08/25 |
10/08/25 |
ASX - By Stock
|
2.4K
|
800K
|
3
|
|
ASX - By Stock
|
ATH Biotech |
Re:
Stock price - ATH/ATHE
|
|
vultureculture
|
2.4K |
800K |
8 |
04/08/25 |
04/08/25 |
ASX - By Stock
|
2.4K
|
800K
|
8
|
|
ASX - By Stock
|
ATH |
Re:
Diseases with brain atrophy ?
|
|
vultureculture
|
11 |
2.8K |
2 |
03/08/25 |
03/08/25 |
ASX - By Stock
|
11
|
2.8K
|
2
|
|
ASX - By Stock
|
ATH |
Re:
Diseases with brain atrophy ?
|
|
vultureculture
|
11 |
2.8K |
1 |
03/08/25 |
03/08/25 |
ASX - By Stock
|
11
|
2.8K
|
1
|
|
ASX - By Stock
|
ATH Biotech |
Re:
Stock price - ATH/ATHE
|
|
vultureculture
|
2.4K |
800K |
2 |
02/08/25 |
02/08/25 |
ASX - By Stock
|
2.4K
|
800K
|
2
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
vultureculture
|
105 |
22K |
4 |
31/07/25 |
31/07/25 |
ASX - By Stock
|
105
|
22K
|
4
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Updated Corporate Presentation
|
|
vultureculture
|
25 |
6.0K |
4 |
31/07/25 |
31/07/25 |
ASX - By Stock
|
25
|
6.0K
|
4
|
|
ASX - By Stock
|
ATH Biotech |
Re:
Stock price - ATH/ATHE
|
|
vultureculture
|
2.4K |
800K |
5 |
31/07/25 |
31/07/25 |
ASX - By Stock
|
2.4K
|
800K
|
5
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Updated Corporate Presentation
|
|
vultureculture
|
25 |
6.0K |
11 |
31/07/25 |
31/07/25 |
ASX - By Stock
|
25
|
6.0K
|
11
|
|
ASX - By Stock
|
ATH Biotech |
Re:
Stock price - ATH/ATHE
|
|
vultureculture
|
2.4K |
800K |
0 |
31/07/25 |
31/07/25 |
ASX - By Stock
|
2.4K
|
800K
|
0
|
|
ASX - By Stock
|
ATH Biotech |
Re:
Elemental Therapeutics are developing PBT2 for AB resistance
|
|
vultureculture
|
10 |
2.7K |
1 |
31/07/25 |
31/07/25 |
ASX - By Stock
|
10
|
2.7K
|
1
|
|
ASX - By Stock
|
ATH Biotech |
Re:
Elemental Therapeutics are developing PBT2 for AB resistance
|
|
vultureculture
|
10 |
2.7K |
1 |
31/07/25 |
31/07/25 |
ASX - By Stock
|
10
|
2.7K
|
1
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
vultureculture
|
105 |
22K |
11 |
30/07/25 |
30/07/25 |
ASX - By Stock
|
105
|
22K
|
11
|
|
ASX - By Stock
|
ATH Biotech |
Re:
Stock price - ATH/ATHE
|
|
vultureculture
|
2.4K |
800K |
13 |
29/07/25 |
29/07/25 |
ASX - By Stock
|
2.4K
|
800K
|
13
|
|
ASX - By Stock
|
ATH Biotech |
Re:
Stock price - ATH/ATHE
|
|
vultureculture
|
2.4K |
800K |
2 |
29/07/25 |
29/07/25 |
ASX - By Stock
|
2.4K
|
800K
|
2
|
|
ASX - By Stock
|
ATH Biotech |
Re:
Stock price - ATH/ATHE
|
|
vultureculture
|
2.4K |
800K |
8 |
29/07/25 |
29/07/25 |
ASX - By Stock
|
2.4K
|
800K
|
8
|
|
ASX - By Stock
|
ATH Biotech |
Re:
Stock price - ATH/ATHE
|
|
vultureculture
|
2.4K |
800K |
4 |
29/07/25 |
29/07/25 |
ASX - By Stock
|
2.4K
|
800K
|
4
|
|
ASX - By Stock
|
ATH Biotech |
Re:
Stock price - ATH/ATHE
|
|
vultureculture
|
2.4K |
800K |
8 |
29/07/25 |
29/07/25 |
ASX - By Stock
|
2.4K
|
800K
|
8
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Positive ATH434 Results from Open-Label Phase 2 Trial in MSA
|
|
vultureculture
|
71 |
21K |
5 |
29/07/25 |
29/07/25 |
ASX - By Stock
|
71
|
21K
|
5
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Positive ATH434 Results from Open-Label Phase 2 Trial in MSA
|
|
vultureculture
|
71 |
21K |
2 |
29/07/25 |
29/07/25 |
ASX - By Stock
|
71
|
21K
|
2
|
|
ASX - By Stock
|
ATH Biotech |
Re:
Stock price - ATH/ATHE
|
|
vultureculture
|
2.4K |
800K |
4 |
28/07/25 |
28/07/25 |
ASX - By Stock
|
2.4K
|
800K
|
4
|
|
ASX - By Stock
|
ATH Biotech |
Re:
Stock price - ATH/ATHE
|
|
vultureculture
|
2.4K |
800K |
5 |
28/07/25 |
28/07/25 |
ASX - By Stock
|
2.4K
|
800K
|
5
|
|
ASX - By Stock
|
ATH Biotech |
Re:
Stock price - ATH/ATHE
|
|
vultureculture
|
2.4K |
800K |
3 |
28/07/25 |
28/07/25 |
ASX - By Stock
|
2.4K
|
800K
|
3
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Peer-Reviewed Publication on Novel MRI Endpoint from bioMUSE
|
|
vultureculture
|
48 |
13K |
2 |
24/07/25 |
24/07/25 |
ASX - By Stock
|
48
|
13K
|
2
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Peer-Reviewed Publication on Novel MRI Endpoint from bioMUSE
|
|
vultureculture
|
48 |
13K |
15 |
24/07/25 |
24/07/25 |
ASX - By Stock
|
48
|
13K
|
15
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Peer-Reviewed Publication on Novel MRI Endpoint from bioMUSE
|
|
vultureculture
|
48 |
13K |
6 |
24/07/25 |
24/07/25 |
ASX - By Stock
|
48
|
13K
|
6
|
|
ASX - By Stock
|
ATH Biotech |
Re:
Stock price - ATH/ATHE
|
|
vultureculture
|
2.4K |
800K |
1 |
23/07/25 |
23/07/25 |
ASX - By Stock
|
2.4K
|
800K
|
1
|
|
ASX - By Stock
|
ATH Biotech |
Re:
Stock price - ATH/ATHE
|
|
vultureculture
|
2.4K |
800K |
6 |
23/07/25 |
23/07/25 |
ASX - By Stock
|
2.4K
|
800K
|
6
|
|
ASX - By Stock
|
ATH Biotech |
Re:
News, articles and interviews
|
|
vultureculture
|
231 |
88K |
1 |
23/07/25 |
23/07/25 |
ASX - By Stock
|
231
|
88K
|
1
|
|
ASX - By Stock
|
ATH Biotech |
Re:
News, articles and interviews
|
|
vultureculture
|
231 |
88K |
6 |
23/07/25 |
23/07/25 |
ASX - By Stock
|
231
|
88K
|
6
|
|
ASX - By Stock
|
ATH Biotech |
Re:
Stock price - ATH/ATHE
|
|
vultureculture
|
2.4K |
800K |
8 |
22/07/25 |
22/07/25 |
ASX - By Stock
|
2.4K
|
800K
|
8
|
|
ASX - By Stock
|
ATH Biotech |
Re:
Stock price - ATH/ATHE
|
|
vultureculture
|
2.4K |
800K |
6 |
22/07/25 |
22/07/25 |
ASX - By Stock
|
2.4K
|
800K
|
6
|
|
ASX - By Stock
|
ATH Biotech |
Re:
Stock price - ATH/ATHE
|
|
vultureculture
|
2.4K |
800K |
1 |
22/07/25 |
22/07/25 |
ASX - By Stock
|
2.4K
|
800K
|
1
|
|
ASX - By Stock
|
ATH Biotech |
Re:
Stock price - ATH/ATHE
|
|
vultureculture
|
2.4K |
800K |
0 |
22/07/25 |
22/07/25 |
ASX - By Stock
|
2.4K
|
800K
|
0
|
|
ASX - By Stock
|
ATH Biotech |
Re:
Stock price - ATH/ATHE
|
|
vultureculture
|
2.4K |
800K |
3 |
22/07/25 |
22/07/25 |
ASX - By Stock
|
2.4K
|
800K
|
3
|
|
ASX - By Stock
|
ATH Biotech |
Re:
Stock price - ATH/ATHE
|
|
vultureculture
|
2.4K |
800K |
0 |
21/07/25 |
21/07/25 |
ASX - By Stock
|
2.4K
|
800K
|
0
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Application for quotation of securities - ATH
|
|
vultureculture
|
1 |
716 |
1 |
21/07/25 |
21/07/25 |
ASX - By Stock
|
1
|
716
|
1
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Application for quotation of securities - ATH
|
|
vultureculture
|
72 |
19K |
2 |
21/07/25 |
21/07/25 |
ASX - By Stock
|
72
|
19K
|
2
|
|
ASX - By Stock
|
ATH Biotech |
Re:
Stock price - ATH/ATHE
|
|
vultureculture
|
2.4K |
800K |
2 |
19/07/25 |
19/07/25 |
ASX - By Stock
|
2.4K
|
800K
|
2
|
|
ASX - By Stock
|
ATH Biotech |
Re:
Stock price - ATH/ATHE
|
|
vultureculture
|
2.4K |
800K |
1 |
18/07/25 |
18/07/25 |
ASX - By Stock
|
2.4K
|
800K
|
1
|
|
ASX - By Stock
|
ATH Biotech |
Re:
Stock price - ATH/ATHE
|
|
vultureculture
|
2.4K |
800K |
3 |
18/07/25 |
18/07/25 |
ASX - By Stock
|
2.4K
|
800K
|
3
|
|
ASX - By Stock
|
ATH Biotech |
Re:
Stock price - ATH/ATHE
|
|
vultureculture
|
2.4K |
800K |
2 |
18/07/25 |
18/07/25 |
ASX - By Stock
|
2.4K
|
800K
|
2
|
|
ASX - By Stock
|
ATH Biotech |
Re:
Stock price - ATH/ATHE
|
|
vultureculture
|
2.4K |
800K |
0 |
18/07/25 |
18/07/25 |
ASX - By Stock
|
2.4K
|
800K
|
0
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Application for quotation of securities - ATH
|
|
vultureculture
|
72 |
19K |
1 |
18/07/25 |
18/07/25 |
ASX - By Stock
|
72
|
19K
|
1
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Application for quotation of securities - ATH
|
|
vultureculture
|
72 |
19K |
4 |
18/07/25 |
18/07/25 |
ASX - By Stock
|
72
|
19K
|
4
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Response to ASX Price Query
|
|
vultureculture
|
55 |
16K |
2 |
17/07/25 |
17/07/25 |
ASX - By Stock
|
55
|
16K
|
2
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Response to ASX Price Query
|
|
vultureculture
|
55 |
16K |
12 |
17/07/25 |
17/07/25 |
ASX - By Stock
|
55
|
16K
|
12
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Response to ASX Price Query
|
|
vultureculture
|
55 |
16K |
6 |
17/07/25 |
17/07/25 |
ASX - By Stock
|
55
|
16K
|
6
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Response to ASX Price Query
|
|
vultureculture
|
55 |
16K |
4 |
17/07/25 |
17/07/25 |
ASX - By Stock
|
55
|
16K
|
4
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Response to ASX Price Query
|
|
vultureculture
|
55 |
16K |
3 |
17/07/25 |
17/07/25 |
ASX - By Stock
|
55
|
16K
|
3
|
|